Back to results
US 2004/0006091 A1Published application
Therapeutic agents useful for treating or preventing pain
AssigneeEuro-Celtique S.A.
InventorsDonald J. Kyle, Qun Sun
Life of this patent
Estimating the term…
Abstract
A compound of formula: 1 (wherein X is O or S and R1, R3, R4, and R5 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Thiadiazolylpiperazine Compound”), pharmaceutical compositions comprising a Thiadiazolylpiperazine Compound, and methods for treating or preventing pain in a patient comprising administering to a patient in need thereof an effective amount of a Thiadiazolylpiperazine Compound are disclosed.
Claims100
A compound of formula:
- 23
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is methyl or halo;
- R3 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, or —(CH2)nOR6, which is unsubstituted or substituted with one or more of —CN, —OH, -halo, —NO2, —CH═NR6, or —NR6OH;
- or
- (b) —H, -halo, —NO2, —CN, or —NH2;
- R4 is —H;
- R5 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, or —(C2-C6)alkynyl;
- or
- (b) —(C3-C8)cycloalkyl, —(C5-C8)cycloalkenyl, -phenyl, -napthyl, —(C4)aryl, —(C3-C7)hetero cycle, —(C1-C6)alkylphenyl, —(C1-C6)alkylnapthyl, —(C1-C6)alkyl(C14)aryl, —(C1-C6)alkyl(C3-C7)heterocycle, —(C2-C6)alkenylphenyl, —(C2-C6)alkenylnapthyl, —(C2-C6)alkenyl(C14)aryl, —(C2-C6)alkenyl(C3-C7)heterocycle, —(C2-C6)alkynyl(C3-C8)cycloalkyl, —(C2-C6)alkynyl(C5-C8)cycloalkenyl, —(C2-C6)alkynylphenyl, —(C2-C6)alkynylnapthyl, —(C2-C6)alkynyl(C14)aryl, or —(C2-C6)alkynyl(C3-C7)heterocycle, which is unsubstituted or substituted with one or more R7 groups;
- each R6 is independently —H, —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(C3-C8)cycloalkyl, —(C5-C8)cycloalkenyl, -phenyl, —(C3-C5)heterocycle, C(halo)3, or CH(halo)2;
- each R7 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-C8)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR6;
- and
- n is an integer ranging from 0 to 2.
13 more elements
A compound of formula:
- 24
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is methyl or halo;
- R3 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, or —(CH2)nOR6, which R3 and R4 are each independently unsubstituted or substituted with one or more of —CN, —OH, -halo, —NO2, —CH═NR6, or —NR6OH;
- or
- (b) —H, -halo, —NO2, —CN, or —NH2;
- R4 is:
- —H;
- R5 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, or —(C2-C6)alkynyl;
- or
- (b) —(C3-C8)cycloalkyl, —(C5-C5)cycloalkenyl, -phenyl, -napthyl, —(C14)aryl, —(C3-C7)heterocycle, —(C1-C6)alkylphenyl, —(C1-C6)alkylnapthyl, —(C1-C6)alkyl(C14)aryl, —(C1-C6)alkyl(C3-C7)heterocycle, —(C2-C6)alkenylphenyl, —(C2-C6)alkenylnapthyl, —(C2-C6)alkenyl(C14)aryl, —(C2-C6)alkenyl(C3-C7)heterocycle, —(C2-C6)alkynyl(C3-C8)cycloalkyl, —(C2-C6)alkynyl(C5-C8)cycloalkenyl, —(C2-C6)alkynylphenyl, —(C2-C6)alkynylnapthyl, —(C2-C6)alkynyl(C]4)aryl, or —(C2-C6)alkynyl(C3-C7)heterocycle, which is unsubstituted or substituted with one or more R7 groups;
- each R6 is independently —H, —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(C3-C8)cycloalkyl, —(C5-C8)cycloalkenyl, -phenyl, —(C3-C5)heterocycle, C(halo)3, or CH(halo)2;
- each R7 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-C8)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR6;
- and
- n is an integer ranging from 0 to 2.
14 more elements
A compound of formula:
- 25
- or a pharmaceutically acceptable salt thereof, wherein:
- X is O or S;
- R1 is —CH3 or -halo;
- R3 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, or —(CH2)nOR6, which is unsubstituted or substituted with one or more of —CN, —OH, -halo, —NO2, —CH═NR6, or —NR6 OH;
- or
- (b) —H, -halo, —NO2, —CN, or —NH2;
- R4 is —H;
- each R8 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-C8)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR6;
- each R6 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, -phenyl, -napthyl, or —(C14)aryl;
- Ar is -phenyl, -napthyl, —(C14)aryl, —(C3-C8)cycloalkyl or —(C5-C8)cycloalkenyl, which is unsubstituted or substituted with one or more R7 groups;
- each R7 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-Cg)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR6;
- n is an integer ranging from 0 to 2;
- and
- p is an integer ranging from 0 to 2.
13 more elements
A compound of formula:
- 26
- or a pharmaceutically acceptable salt thereof, wherein:
- X is O or S;
- R1 is —CH3 or -halo;
- R3 is:
- (a) —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, or —(CH2)nOR6, which is unsubstituted or substituted with one or more of —CN, —OH, -halo, —NO2, —CH═NR6, or —NR6OH;
- or
- (b) —H, -halo, —NO2, —CN, or —NH2;
- R4 is —H;
- each R8 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-C8)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR6;
- each R6 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, -phenyl, -napthyl, or —(C14)aryl;
- Ar is -phenyl, -napthyl, —(C14)aryl, —(C3-C8)cycloalkyl or —(C5-C8)cycloalkenyl, which is unsubstituted or substituted with one or more R7 groups;
- each R7 is independently —(C1-C6)alkyl, —(C2-C6)alkenyl, —(C2-C6)alkynyl, —(CH2)n(C3-C8)cycloalkyl, —(CH2)n(C5-C8)cycloalkenyl, —(CH2)nphenyl, —(CH2)nSR6, —(CH2)nCH(halo)2, —(CH2)nC(halo)3, -halo, —(CH2)nOR1;
- n is an integer ranging from 0 to 2;
- and
- p is an integer ranging from 0 to 2.
13 more elements
Dependencies are inferred from the claim text.